Elkfork Partners’s West Pharmaceutical WST Stock Holding History

Elkfork Partners’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$1.38M	Hold	9,702	–	–	0.03%	323
2019 Q2	$1.21M	Hold	9,702	–	–	0.03%	355
2019 Q1	$1.07M	Hold	9,702	–	–	0.03%	364
2018 Q4	$951K	Buy	9,702 +286	+3%	+$31K	0.03%	360
2018 Q3	$1.16M	Buy	9,416 +1,760	+23%	+$197K	0.03%	345
2018 Q2	$760K	Hold	7,656	–	–	0.02%	415
2018 Q1	$676K	Hold	7,656	–	–	0.02%	441
2017 Q4	$755K	Buy	7,656 +1,188	+18%	+$116K	0.02%	423
2017 Q3	$623K	Buy	6,468 +902	+16%	+$81.6K	0.02%	435
2017 Q2	$526K	Buy	5,566 +2,178	+64%	+$200K	0.02%	484
2017 Q1	$277K	Buy	3,388 +506	+18%	+$42.3K	0.01%	544
2016 Q4	$245K	Buy	+2,882	New	+$227K	0.01%	534

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Elkfork Partners's WST Position: Q3 2019 in Review

Elkfork Partners held its West Pharmaceutical (WST) position steady in Q3 2019 at 9,702 shares worth $1.38M. The position accounts for 0.03% of the portfolio, ranked #323.

Elkfork Partners first reported a position in WST in Q4 2016 and has held it in 12 quarters since. 406 funds tracked by Wall St. Rank hold WST as of Q3 2019.

Elkfork Partners held 9,702 shares of West Pharmaceutical worth $1.38M as of Q3 2019.
Elkfork Partners left its West Pharmaceutical share count unchanged in Q3 2019.
West Pharmaceutical made up 0.03% of Elkfork Partners's portfolio in Q3 2019, its #323 holding.
Elkfork Partners first reported a position in West Pharmaceutical in Q4 2016 and has held it in 12 quarters since.
406 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.